151 related articles for article (PubMed ID: 21136126)
1. Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression.
Andre K; Kampman O; Setälä-Soikkeli E; Viikki M; Poutanen O; Nuolivirta T; Mononen N; Lehtimäki T; Leinonen E; Illi A
J Neural Transm (Vienna); 2010 Dec; 117(12):1431-4. PubMed ID: 21136126
[TBL] [Abstract][Full Text] [Related]
2. SERT and NET polymorphisms, temperament and antidepressant response.
Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
Tomita T; Kaneda A; Nakagami T; Kaneko S; Yasui-Furukori N
Hum Psychopharmacol; 2015 Sep; 30(5):334-40. PubMed ID: 25845342
[TBL] [Abstract][Full Text] [Related]
4. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
[TBL] [Abstract][Full Text] [Related]
6. The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder.
Li HF; Yu X; Yang K; He CY; Kou SJ; Cao SX; Xie GR
Genet Test Mol Biomarkers; 2012 Jul; 16(7):667-71. PubMed ID: 22480177
[TBL] [Abstract][Full Text] [Related]
7. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients.
Kampman O; Poutanen O; Illi A; Setälä-Soikkeli E; Viikki M; Nuolivirta T; Leinonen E
Eur Psychiatry; 2012 May; 27(4):245-9. PubMed ID: 20933372
[TBL] [Abstract][Full Text] [Related]
8. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
[TBL] [Abstract][Full Text] [Related]
9. BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression.
Andre K; Kampman O; Viikki M; Setälä-Soikkeli E; Illi A; Mononen N; Lehtimäki T; Leinonen E
Acta Neuropsychiatr; 2018 Jun; 30(3):168-174. PubMed ID: 29310728
[TBL] [Abstract][Full Text] [Related]
10. TPH1 A218C polymorphism and temperament in major depression.
Andre K; Kampman O; Viikki M; Illi A; Setälä-Soikkeli E; Poutanen O; Mononen N; Leinonen E; Lehtimäki T
BMC Psychiatry; 2013 Apr; 13():118. PubMed ID: 23597148
[TBL] [Abstract][Full Text] [Related]
11. Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.
Viikki M; Huuhka K; Leinonen E; Illi A; Setälä-Soikkeli E; Huuhka M; Mononen N; Lehtimäki T; Kampman O
Neurosci Lett; 2011 Aug; 501(1):20-4. PubMed ID: 21741447
[TBL] [Abstract][Full Text] [Related]
12. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Illi A; Setälä-Soikkeli E; Viikki M; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E; Kampman O
Neuroreport; 2009 Aug; 20(12):1125-8. PubMed ID: 19590397
[TBL] [Abstract][Full Text] [Related]
13. 5-HT2A SNPs and the Temperament and Character Inventory.
Serretti A; Calati R; Giegling I; Hartmann AM; Möller HJ; Colombo C; Rujescu D
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1275-81. PubMed ID: 17590256
[TBL] [Abstract][Full Text] [Related]
14. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
15. 5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study.
Liang CS; Ho PS; Chiang KT; Su HC
J Sex Med; 2012 Aug; 9(8):2009-16. PubMed ID: 22612784
[TBL] [Abstract][Full Text] [Related]
16. Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Perlis RH; Fijal B; Adams DH; Sutton VK; Trivedi MH; Houston JP
Biol Psychiatry; 2009 May; 65(9):785-91. PubMed ID: 19095219
[TBL] [Abstract][Full Text] [Related]
17. Temperament and character influence on depression treatment outcome.
Balestri M; Porcelli S; Souery D; Kasper S; Dikeos D; Ferentinos P; Papadimitriou GN; Rujescu D; Martinotti G; Di Nicola M; Janiri L; Caletti E; Mandolini GM; Pigoni A; Paoli RA; Lazzaretti M; Brambilla P; Sala M; Abbiati V; Bellani M; Perlini C; Rossetti MG; Piccin S; Bonivento C; Fabbro D; Damante G; Ferrari C; Rossi R; Pedrini L; Benedetti F; Montgomery S; Zohar J; Mendlewicz J; Serretti A
J Affect Disord; 2019 Jun; 252():464-474. PubMed ID: 31005789
[TBL] [Abstract][Full Text] [Related]
18. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
19. An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder.
Tomita T; Ishioka M; Kaneda A; Sugawara N; Nakagami T; Nakamura K; Yasui-Furukori N
J Affect Disord; 2014 Aug; 165():109-13. PubMed ID: 24882186
[TBL] [Abstract][Full Text] [Related]
20. The influence of personality factors on paroxetine response time in patients with major depression.
Kaneda A; Yasui-Furukori N; Nakagami T; Sato Y; Kaneko S
J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
